Markel Q1 2026: Underwriting Holds at 95% Combined Ratio, but Global Reinsurance Run-Off and Investment Volatility Weigh
Read source articleWhat happened
Markel Group reported Q1 2026 results on April 30, with earnings per share of $12.11, a sharp drop from the prior year's $75.56, largely due to lower net investment gains and catastrophe losses. The Insurance segment posted a combined ratio of 95% for the quarter, consistent with the full-year 2025 level, indicating underwriting discipline is holding despite a moderating pricing environment. However, the Global Reinsurance run-off continues to be a drag, with a 106.7% combined ratio and an underwriting loss of $17.9 million, and the division is expected to take 2-3 years to fully run off. Non-insurance operations (Industrial, Financial, Consumer) contributed $634 million in adjusted operating income for 9M 2025, growing modestly and providing some earnings diversification. The stock trades at approximately 1.43x book value and 12.4x trailing EPS, reflecting a premium for its hybrid insurance-investment model but leaving limited margin of safety for underwriting or market shocks.
Implication
Markel's diversified model (insurance float, equity portfolio, private businesses) supports a mid-teens intrinsic value compounder thesis, but current pricing offers only modest upside. The 2025 full-year results (expected early 2026) will be a key catalyst to confirm sustained underwriting improvement and run-off progress. Long-term investors should build positions on weakness toward $1,800, where the margin of safety is more compelling.
Thesis delta
The DeepValue report's 'Wait' rating and $2,038 valuation are reinforced by the Q1 earnings—the Insurance combined ratio remains respectable, but the earnings miss and persistent Global Reinsurance losses underscore the lack of margin of safety at current prices. No material shift in the thesis occurs; the analysis continues to favor waiting for a pullback toward 1.25-1.3x book or clearer evidence of reduced volatility. The Q1 result serves as a checkpoint that validates the report's assessment of the risk/reward being unattractive at current levels.
Confidence
3.0